Home » Topics » BioWorld Science

BioWorld Science
RSS

Theralase seeks Canadian clearances for phase II study of TLD-1433 in bladder cancer

Aug. 23, 2018

Study yields surprise findings on costimulatory domains

Aug. 23, 2018

Combined approaches used to obtain selective Nav1.7 inhibitors

Aug. 23, 2018

LLY-283 demonstrates promising antitumor activity in vitro and in vivo

Aug. 23, 2018

Berlin Cures completes phase I study of BC-007 for cardiomyopathy

Aug. 22, 2018

Biosceptre initiates phase I trial with peptide cancer vaccine BIL-06v

Aug. 22, 2018

Hanmi Science synthesizes new protein kinase inhibitors

Aug. 22, 2018

Ono announces new Japanese approvals for Opdivo

Aug. 22, 2018

Araxes Pharma patents KRAS inhibitors

Aug. 22, 2018

Sun Pharma Advanced Research Co. identifies estrogen receptor antagonists

Aug. 22, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...